Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

BioTheryX

Request full access

A clinical-stage company harnessing deep expertise in Targeted Protein Degradation to restore protein homeostasis in order to treat a wide range of diseases

San Diego, United StatesFounded 2008Biotech & Life Sciences

About BioTheryX

Biotheryx is a biotechnology startup that specializes in the design and development of targeted protein degraders. These are a new class of drugs that work by binding to disease-causing proteins in the body and marking them for destruction. The company's main focus is on developing treatments for cancer and inflammatory diseases, two areas with significant unmet medical needs.

Biotheryx's proprietary PRODEGY (Protein Degrader Technology) platform is at the heart of its business. This platform uses the company's expertise in modulating a protein called Cereblon to design targeted protein degraders. Modulating means altering the activity of Cereblon in ways that have never been done before, which could lead to new treatments for diseases.

The company generates revenue by developing a pipeline of these protein degraders and partnering with other companies to bring them to market. For example, in April 2023, Biotheryx announced a research collaboration and license agreement with Incyte, a pharmaceutical company, for the discovery of targeted protein degraders for novel oncology targets.

Biotheryx also presents its preclinical findings at various scientific meetings, which helps to raise its profile in the biotech industry and attract potential partners and investors.

In summary, Biotheryx operates in the biotech market, serving clients in the pharmaceutical industry. Its business model revolves around the development of targeted protein degraders for the treatment of cancer and inflammatory diseases, and it makes money through partnerships and licensing agreements.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2008
Headquarters
San Diego, United States
Employees
25
Open positions
None listed
Dealroom signal
69.2/100
Industry
Health
Sub-industry
BioTechnology
Sector
Biotech & Life Sciences, Biotechnology, Oncology, Biotech and Pharma, Hard Tech, proteomics, DT and LS, science-based
Business model
Manufacturing
Client focus
B2B

Funding history

6 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES EOther financing May 2021 $92M $368M Tekla Capital Management · Point72 Ventures · Alexandria Venture Investments · Avidity Partners ↗
SERIES DOther financing Jul 2020 $35M $140M MSD Partners ↗
Showing the latest 2 of 6 recorded eventsBook a demo for the full funding history →

Growth signals

BioTheryX website traffic

Latest recorded traffic for BioTheryX is 3.9K monthly website visits, up 116.7% over the last three months. BioTheryX's team grew 0% over the past year.

Latest monthly visits3.9K 3-month web change+116.7% 1-year team growth0%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
Nexo TherapeuticsUses a combination of covalent ligand discovery and chemical biology to develop new cancer therapies Golden, United States Operational 19 $60M $240M
DISCO PharmaceuticalsBiotechnological research as well as the development, production and distribution of biotechnological products and solutions of all kinds Cologne, Germany Operational
BAKX TherapeuticsWe create targeted cancer therapies through unique insights into the conformationally dynamic protein drivers of the mitochondrial apoptosis pathway combined with structure-based drug design and computational simulations Kingston, United States Closed
Interline TherapeuticsLeveraging advances in genomics, proteomics, and computational chemistry to identify new medicines San Francisco, United States Operational
PROSION TherapeuticsPROSION Therapeutics is a drug development company with a proprietary platform that addresses highly unmet medical needs by unlocking undruggables Cologne, Germany Operational
ExogeneBiotechnology company accelerating target and TCR discovery for cancer cell therapies using AI-enabled TCR-antigen screening Oxford, United Kingdom Operational
Eisbach BioInnovative start-up in biotechnology developing novel drugs that successfully target molecular vulnerabilities arising in cancer genomes Planegg, Germany Operational
Aro BiotherapeuticsFocused on the development of a new protein drug platform Philadelphia, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

BioTheryX in the San Diego ecosystem

Live from Dealroom

The BioTheryX office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

14 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series B and later13 investors entered at this stage

  • MSD Partners
  • Farallon Capital Management
  • Tekla Capital Management
  • Point72 Ventures
  • Alexandria Venture Investments
  • Avidity Partners
  • Deep Track Capital
  • Rock Springs Capital
  • Janus Henderson Investors
  • Irving Investors
  • Lumira Ventures
  • Wedbush Ventures
  • Surveyor Capital
Team profiled 8 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about BioTheryX on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See BioTheryX’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.